- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
ErbB2 receptor tyrosine kinase 2 (ERBB2), also known as HER2, is a transmembrane receptor tyrosine kinase encoded by the ERBB2 gene and widely expressed in epithelial and tumor tissues, where it plays a central role in cell signaling and growth regulation. HER2 Antibody / Receptor Tyrosine Kinase Antibody (clone ERBB2/3257) targets this protein, which is primarily localized to the cell membrane with additional cytoplasmic distribution reflecting receptor internalization and turnover. HER2 antibody, also referred to as ErbB2 antibody and ERBB2 antibody in the literature, detects a key signaling receptor involved in oncogenic pathways and cellular proliferation. This antibody is part of a collection of Human Protein Microarray validated antibodies that have been screened for specificity across thousands of proteins.
Functionally, HER2 is a member of the epidermal growth factor receptor (EGFR) family and participates in ligand-independent dimerization and activation of downstream signaling cascades, including the PI3K/AKT and MAPK pathways. These pathways regulate cell proliferation, survival, and differentiation. HER2 signaling is particularly important in cancer biology, where overexpression or amplification of ERBB2 leads to enhanced tumor growth and progression. This makes HER2 one of the most extensively studied receptor tyrosine kinases in oncology.
HER2 expression is commonly observed in epithelial tissues and is frequently elevated in cancers such as breast, gastric, and ovarian carcinoma. In tissue sections, immunohistochemical staining typically reveals strong membranous localization in tumor cells, reflecting its function as a cell surface receptor. In addition to tumor cells, HER2 expression may also be detected in normal epithelial structures at lower levels.
Structurally, HER2 consists of an extracellular ligand-binding domain, a single transmembrane region, and an intracellular tyrosine kinase domain responsible for signal transduction. Unlike other EGFR family members, HER2 does not have a known direct ligand and instead functions as a preferred dimerization partner, amplifying signaling through heterodimer formation. This property contributes to its potent signaling capacity in both normal and pathological conditions.
Altered HER2 expression is strongly associated with cancer progression and therapeutic response. HER2-positive tumors are characterized by aggressive growth and are targeted by specific therapies that inhibit receptor signaling. Beyond oncology, HER2 signaling contributes to normal tissue development and cellular communication.
Protein microarray validation demonstrates highly specific binding of this antibody to HER2 with minimal off-target interaction, supporting reliable detection of this receptor tyrosine kinase. Combined with immunohistochemistry and flow cytometry data, this antibody provides robust detection across multiple experimental applications.
For a full selection of HER2 antibodies for research applications, see our HER2 antibody page.
Optimal dilution of the HER2 Antibody / Receptor Tyrosine Kinase Antibody should be determined by the researcher.
1. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.
A recombinant human HER-2/ERBB2 protein fragment within amino acids 311-462 was used as the immunogen for the HER2 antibody.
Store the HER2 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
HER2 antibody, ErbB2 antibody, ERBB2 antibody, HER2 receptor antibody, ErbB2 receptor tyrosine kinase antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.